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Research Problem / Aim: The ventrogluteal injection area is one of the areas most frequently 
used by nurses in intramuscular injection applications. The thicknesses of the subcutaneous tissue 
and the muscle tissue in this area are important for a safe injection. The aim of this study is the 
determination of the subcutaneous and muscle tissue thicknesses on the ventrogluteal injection 
area and the anthropometric data about it.  
Method: The study has designed a cross-sectional study. 150 individuals who applied to the 
ultrasound unit of the hospital and accepted to participate in the study were included in the study. 
The ventrogluteal injection area was determined with the ‘’V’’ method by the researcher. The 
subcutaneous and muscle tissue thicknesses from the areas on the injection area and the areas 2 
and 4 cm around the injection area were determined using the ultrasound device. Moreover, the 
relation between the anthropometric measurements of the individuals (height, weight, waist, hip 
and crista iliaca circumferences, distance between the large trochanter and crista iliaca and crista 
iliaca anterior) and the tissue thicknesses on the injection area were evaluated. The data of the 
research were evaluated with definitive statistics, ANOVA test and posthoc Tukey test, t test and 
correlation analysis. The p<0.05 value was accepted as statistically significant for all results. 
Findings: The average subcutaneous tissue thickness in the injection area was determined as 
15.44±8.01 mm and the average tissue thickness there was determined as 31.75±11.86 mm. The 
subcutaneous tissue thickness in women was found more than the subcutaneous tissue thickness 
in men. When the tissue thicknesses 2 and 4 cm around the injection area were analyzed, it was 
found that the area where the total tissue thickness was the least was over 2 cm (41.67±14.83) 
and over 4 cm (35.79±15.55) of the injection area. It was determined that the average total 
thickness 4 cm around the injection area was less than 38 mm in underwight individuals.  
Conclusions: According to the results obtained from the study, the weight and body mass index 
of the individual should be considered in the choice of the injection area and the length of the 
needle to be used when the ventrogluteal injection area was used in intramuscular injections. 
Especially in obese individuals, longer needles can be preferred. Besides, it must be thought that 
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there may be the risk of bone injury 4 cm around the injection area in asthenic individuals and 
individuals with normal weight. Moreover, since the individuals’ having a large waist and hip 
circumference is related to their subcutaneous tissue thickness, it is recommended that long 
needles should be chosen in these individuals.  
Keywords: Intramuscular injection, nursing practise, ventrogluteal area.  
Introduction 
The intramuscular injection application is one of the medicine applications which are among 
the important functions of nurses. In intramuscular injections, the medicine passes the 
subcutaneous tissue and it is injected into the deep muscle tissue. The intramuscular injection 
should be applied on an area away from large blood vessels, nerve structures and the bone tissue 
(Potter & Perry, 2013).  The correct determination of the area is very important in terms of the 
safety of the patient and the complications to develop. The dorsogluteal and the ventrogluteal 
areas on the hip, the detoid muscle on the arm and the vastus lateralis and the rectus femoris 
muscles on the leg are used for intramuscular injections (Cocoman & Murray, 2010; Hunter, 
2008). In recent years, in the evidence about the intramuscular injection application, it is reported 
that the ventrogluteal injection area is the most reliable area (Cocoman & Murray, 2010; Potter & 
Perry, 2013;). The ventrogluteal injection area was used by Hochstetter in the early 1950s for the 
first time. The ventrogluteal injection area consists of the gluteus medius and the gluteus minimus 
muscles (Malkin, 2008; Nicoll & Hesby, 2002; Potter & Perry, 2013). In this area, the 
subcutaneous tissue thickness is less than the other injection areas (Hemsworth, 2000; Hunter, 
2008) and the nerves and the veins are relatively less intensive. The subcutaneous fat tissue’s 
being thin prevents giving the medicine to the fat tissue instead of the muscle tissue by mistake. 
Although the ventrogluteal area does not contain major nerves and blood vessels, minor nerve 
damages and hemorrhage because of the blood vessels in this area may occur. However, serious 
nerve damages do not occur in this area. In addition, the ventrogluteal area is an area which is 
preferred more than the dorsogluteal area because the patients can be given position easily 
(Cocoman & Murray, 2010; Wyaden, Landsborough, McGowan, Baigmohamad, Finn & 
Pennebaker, 2006). Moreover, it is easier to find the anatomical border points for the injection 
application. In the medical literature, it is reported that the muscles in the ventrogluteal area are 
more developed in adults and children, they can be used after seven months especially in children 
and the area is also a suitable area for intensive and irritating medicines (Zimmermann, 2010; 
Hunt, 2008). In the research made, it was also indicated that the complications such as fibrosis, 
nerve damage, abscess, tissue necrosis, muscle contraction, gangrene, and pain are related to the 
injections applied to the areas other than the ventrogluteal (VG) area (Nicoll & Hesby, 2002; 
Zimmermann, 2010).  
Although the medical literature recommends the ventrogluteal injection area for 
intramuscular injections, most nurses do not prefer this area primarily. The nurses’ rates for 
preferring the area was reported as 17.1 %  (Sarı, Şahin, Yaşar, Taşkıran & Telli, 2017), 24,8 % 
(Tuğrul & Denat, 2014) and 7.4 % (Gülnar & Çalışkan,2014). The nurses stated that their reason 
for not preferring the area was the difficulty of the determination of the area and the differences 
in the individuals’ body structures making the determination of the area difficult (Donaldson & 
Green, 2005; Greenway, 2014; Tuğrul & Denat, 2014). In several studies analyzing the rates of 
the subcutaneous tissue and the muscle tissue of the ventrogluteal area  (Larkin, Ashcroft, 
Elgellaie & Hickey, 2017; Nisbet,2006), it was determined that gender and body mass index were 
the factors affecting a safe injection. Moreover, it was reported that waist circumference, hip 
circumference and the distance between the large trochanter and crista iliaca and crista iliaca 
anterior superior were also the factors affecting a safe injection (Kaya, Salmaslıoğlu, Terzi & 
Turan, 2015; Larkin, Ashcroft, Elgellaie & Hickey, 2017).  
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In the intramuscular injection, long needles can be needed for the needle to pass the fat 
tissue and advance to the deep muscle tissue. The length of the needle should be chosen 
according to the weight and the fat tissue thickness of the patient (Potter & Perry, 2013; Taylor, 
Lillis, LeMone & Lynn, 2011). The patient’s body mass index is a determinative factor in the fat 
tissue’s being thick. 32 mm, 35 mm and 38 mm long needles are commonly used in intramuscular 
injection applications in adults. The medicine should advance at least 5 mm in the muscle tissue 
for it to be given to the deep muscle tissue. Otherwise, the medicine cannot reach the muscle 
tissue and it is given to the fat tissue. In the injections made with a 32 mm long needle, it is 
impossible for the needle to reach the muscle tissue if the subcutaneous tissue is 25 mm thick or 
more. When the medicine is given to the fat tissue, it is absorbed more slowly, the effect of the 
medicine diminishes and tissue damages may occur (Cocoman & Murray, 2008; Wynaden, 
Landsborough, McGowan, Baigmohamad, Finn & Pennebaker, 2008). In situations in which the 
muscle tissue and the total tissue thickness are insufficient, bone osteonecrosis and pain may 
develop (Cook, 2015). When 32 mm long needles are used, the total fat tissue and the muscle 
tissue thickness should be at least 35 mm. In conclusion, the subcutaneous tissue should be 
thinner than 25 mm and the total tissue thickness should be at least 35 mm for safe injections. 
The thickness of the subcutaneous, fat and muscle tissues determine if the injection is made 
correctly and the medicine is injected into the fat tissue or the bone tissue in gluteal injections 
(Kaya, Turan & Palloş, 2012; Nispet, 2006;). Each of the factors such as the body structure, 
gender, and age are directly related to the muscle tissue thickness and total tissue thickness for 
the intramuscular injections in individuals (Palma & Strohfus, 2013).  
Incorrect administration of ventrogluteal injections carries significant risks for the patient. 
In studies examining the tissue thickness in this region, only the tissue thickness at the injection 
point was determined. In our study, tissue thicknesses around 2 cm and 4 cm of the injection 
point were determined and compared with the anthropometric measurements of the individuals. 
In this respect, it is thought that this study will contribute to the literature. 
 
Method and Material 
The study was conducted in a cross‐sectional design. The aim of this research is to obtain 
the subcutaneous and muscle tissue thicknesses on the ventrogluteal injection area and the 
anthropometric data. 
            Participants/sample 
The research was conducted at Adnan Menderes University Research and Application 
Hospital Radiology Unit ultrasound department between 01.07.2015 and 01.05.2016. In the 
research, the calculation of the sample size was based on a study by Kaya et al (2015) in which 
the muscle and fat tissues in the ventrogluteal area were determined.  
In the analysis performed on the study data in this study, using  G∗Power 3.1.9.2 software 
at power: 0.80, α = 0.05, sample size was calculated to be 145, and using the t-test, effect size was 
calculated as 0.237. In our study, minimum sample size was calculated with G∗Power 3.1.9.2 such 
that effect size: 0.30, α = 0.05, power: 0.80, with the assumption that a t-test would be 
performed; the calculations yielded a sample size of 143. On the basis of the convenience sample 
method and taking into consideration possible case losses, 150 individuals (75 women and 75 
men) were recruited into the study. The individuals included in the study were stratified according 
to age (18-65 ages), body mass index (18,5-40 kg/m2 ) and gender. 150 individuals, 75 women and 
75 men, 50 people for each group, were included in the study according to the stratified sampling 
method. 
           Criteria for Being Included in the Research 
     Individuals between 18-65 ages with normal body mass index (BMI) (18.5-24.9 kg/m2),  
who were overweight (25-29.9 kg/m2) and obese (30-40 kg/m2) were included in the study. In 
order to determine the ventrogluteal injection area comfortably, individuals without any 
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anatomical disorder were included. Since the individuals were given side-lying position while the 
injection area was being determined, individuals who could lie in the side-lying position were 
included in the scope of the research.  
           Instruments 
     The data collection form, an ultrasound device, a ruler and a tape were used in the 
collection of the research data. The data collection form was prepared by the researchers in 
accordance with the literature (Hunter, 2008, Larkin, Ashcroft, Elgellaie & Hickey, 2017; Potter 
& Perry,2013;). The data collection form consists of three parts. In the first part, there are the 
definitive characteristics of the individuals (age, height, weight, body mass index and gender). 
There is the chart where the waist and hip measurements are recorded (waist, hip and crista iliaca 
circumference and the distance between trochanter-crista iliaca and crista iliaca anterior superior) 
in the second part. There is the chart where the subcutaneous and muscle tissue thicknesses in 
the ventrogluteal area are recorded in the third part. The individuals’ waist and hip circumference 
measurements were made with a tape. The subcutaneous and muscle tissue thicknesses in the 
ventrogluteal area were measured with a superficial ultrasound device with a 2 cm wide probe. 
The pre-application of the study was made with 20 individuals who did not participate in the 
sample group and accepted to participate in the application. In consequence of the pre-
application, necessary corrections were made in the data collection form and the chart. 
            Data collection 
In the data collection stage, first the introductory information of the individuals was taken 
and their height-weight, waist, hip and crista iliaca circumference measurements were made by a 
researcher. While the individuals were lying on the stretcher in the side-lying position, their 
clothes were taken off leaving the ventrogluteal area on their left hips naked. The researcher 
determined the ventrogluteal area with hands while the individual was in this position. The 
middle point of the triangle formed between the forefinger and the middle finger was marked 
with a pen (Figure 1). Points 2 and 4 cm right, left, above and below the middle point were 
determined with a ruler and these points were marked. The marking of the areas was made with a 
pen which would not be erased with the ultrasound gel. Then, the subcutaneous and muscle 
tissue thicknesses were determined from each point determined. The ultrasound probe was 
placed on the injection points determined by the radiology specialist with a 90-degree angle, the 
needle’s angle of entrance to the tissue while applying an intramuscular injection (Figure 3). The 
subcutaneous and muscle tissue thicknesses on each point determined were measured and 
recorded.  
          Data analysis  
          The analysis of the data obtained from the research was made using SPSS 18 (Statistical 
Package for Social Sciences) package software. Conformation to the normal dispersion in 
numerical variables was researched with a Shapiro – Wilk test and it was determined that the 
research data conformed to the normal dispersion. The data of the research were evaluated with 
the definitive statistics, ANOVA test and posthoc Tukey test, independent samples t -test, and 
Pearson’s correlation test. The p<0.05 value was accepted as statistically significant for all results. 
            Ethical Approval 
Written permissions from Adnan Menderes University Faculty of Medicine Ethics 
Committee (No:71146310/2015-AC-CE-44) and Adnan Menderes University Research and 
Application Hospital were taken for the research to be conducted. Written and verbal 
permissions were taken from the individuals who participated in the research. 
Results 
            A total of 150 participants, 75 (50%) females and 75 (50%) males, completed this study. 
Males are significantly taller than females, but there is no gender difference for weight and BMI. 
According to World Health Organization’ classification of body mass index; 33.3% of 
participants had normal weight, 33.3% were overweight and 33.3% were obese. The individuals’ 
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waist circumference average is 83.1±12.3 cm. It is 81.9±11.5 cm in women and 100.0±13.3 cm in 
men. The crista iliaca circumference measurement average is 95.1±12.4 cm; 96.6±12.5 cm in 
women and 93.5±12.2 cm in men.  
            The subcutaneous tissue thickness average on the injection area was determined as 
15.44±8.01 mm and the muscle tissue thickness was determined as 46.98±14.08 mm. It was 
determined that the difference between the subcutaneous tissue thicknesses on the injection area 
in men and women were significant. It was determined that there was no significant difference 
between the muscle tissue thicknesses and the total tissue thicknesses. However, it was 
determined that the difference between the individuals’ body mass indexes and the subcutaneous 
tissue, muscle tissue and total tissue thicknesses on the injection area was statistically significant. 
In the statistical analysis (Tukey test) conducted to find the source of the difference determined 
between the tissue thicknesses in the injection area and the body mass index, the difference was 
found to be caused by individuals with a body mass index of 30-39.8 kg/m2 in the subcutaneous 
tissue thickness. It was found that it was caused by individuals with body mass index 18.5-24.9 
kg/m2 and 25-29.9 kg/m2 in thickness of muscle tissue. The source of the difference in total 
tissue thickness was determined to originate from all groups (Table 1). 
Table 1. Dispersion of the subcutaneous tissue, muscle tissue and total tissue thicknesses 
according to gender and body mass ındex 
 
Gender  
S.C. tissue thickness 
(mm) 
Muscle tissue thickness 
(mm) 
Total tissue thickness 
(mm) 
Mean±SD Mean±SD Mean±SD 
Female   
Male  
17.04±8.20 30.22 ±12.30 47.26±15.02 
13.85±7.54 32.84±11.33 46.69±13.18 
         t=2.47    p=0.00       t=-1.35   p=0.178   t=0.248   p=0.140 




12.31±6.02 28.25±11.98* 40.57±13.56* 
13.34±6.06 34.02±11.47* 47.36±11.98* 
20.68±8.94* 32.32±11.60 53.01±14.02* 
F=20.45      p=0.00 F=3.22      p=0.00 F=11.09     p=0.00 
Difference c a,b a,b,c 
SD: Standart Deviation, t: independent samples t –test,   F: ANOVA test, *Posthoc Tukey test 
 
       In the study, the relationship between subcutaneous tissue thickness, muscle tissue thickness, 
total tissue thickness, age, trochanter - cıas distance, trochanter - crista ıliaca distance, and height, 
weight, waist, hip and crista iliaca circumference at the ventrogluteal injection site were examined. 
Accordingly, it was determined that there was a moderate positive correlation between the 
thickness of the subcutaneous tissue and the circumference of the weight, waist, hip and crista 
iliaca. It has been determined that there is a weak correlation between total tissue thickness and the 
length of weight, waist, hip and crista iliaca circumference. It was determined that there was a weak 
relationship between height, weight and there was a positive weak relationship between the distance 
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Table 2. Pearson’s correlation between the tissue thicknesses on the ventrogluteal ınjection 
area and age, height, weight, waist and hip circumference measurements 
r: Pearson’s correlation value, ** p<0,05 
 
         In the study, subcutaneous and muscle tissue thicknesses of the ventrogluteal injection site 
around 2 cm and 4 cm were measured. The average of tissue thicknesses in these regions are given 
in table 3. According to this; It was determined that the place where the average of subcutaneous 
tissue, muscle tissue and total tissue thickness was the thinnest was 4 cm above the injection site 
and the thickest was.4 cm right the injection site (Table 3). 
 
Table 3. The subcutaneous and muscle tissue thicknesses 2 cm and 4 cm around the 
















      Mean±SD      Mean±SD       Mean±SD 
           2 cm Above  13.70±7.20 27.97±12.06 41.67±14.83 
           2 cm Below  16.40±8.21 29.61±12.29 46.01±14.29 
           2 cm Right  17.03±8.14 32.71±11.92 49.74±14.12 
            2 cm Left  14.34±7.81 30.91±12.63 45.26±14.85 
4 cm around the Injection 
Area 
 
4 cm Above  11.94±6.57 23.85±12.39 35.79±15.55 
4 cm Below  16.73±8.34 26.68±12.40 43.41±13.86 
4 cm Right  17.90±8.78 33.47±12.29 51.37±13.77 
4 cm Left  13.15±7.38 29.28±13.56 42.43±15.58 












r / p r / p r / p r / p r / p 
S.C. Tissue 
Thickness 
-0.096/0.242 0.414**/0.000 0.412**/0.000 0.533**/0.000 0.463**/0.000 
Muscle Tissue 
Thickness 
0.018/0.826 0.089/0.280 0.041/ 0.620 -0.040/0.626 -0.031/0.707 
Total Tissue 
Thickness 
-0.039/0.632 0.310**/0.000 0.269**/0.001 0.270**/0.001 0.238**/0.003 








0.341**/0.000 0.258**/0.001 0.107/0.194 0.240**/0.003 0.078/0.345 
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According to the findings obtained, while the tissue thicknesses were the least 2 cm around 
the injection area in the individuals whose body mass indexes were between 18.5-24.9 kg/m2, the 
tissue thicknesses were found the highest in the individuals whose body mass indexes were between 
30-40 kg/m2. It was determined that the area where the total tissue thickness was the lowest was 2 
cm above the injection area in individuals with body mass index between 18.5-24.9 kg/m2  The area 
where the total tissue thickness was the highest was determined as 2 cm right of the injection area 
in the individuals with body mass index between 30-40 kg/m2 . It was determined that the 
difference between the subcutaneous tissue thickness averages was statistically significant 2 cm 
around the injection area according to the body mass index. According to the statistical analysis 
(Tukey test) to determine which group this difference originated from, the difference between the 
tissue thicknesses above 2 cm of the injection point and the body mass index was determined from 
all groups. It was determined that the difference between the tissue thickness and body mass index 
2 cm below the injection point, to the right and left of the injection point originated from the group 
with a body mass index of 18.5-24.9 kg/m2 (Table 4). 
Table 4. Total Tissue Thickness Averages of the Points Determined Around 2 Cm of the 
Injection Point and the Body Mass Index Averages of the Individuals. 
  F: ANOVA test, *Posthoc Tukey test 
 
Whether there was a difference between the total tissue thicknesses 4 cm around the 
ventrogluteal injection area and the body masses of the individuals was analyzed.  According to this, 
it was determined that the area where the tissue thickness was the least in the individuals with body 
mass index between 18.5-24.9 kg/m2 was 4 cm above the injection point and the area where it was 
the thickest was 4 cm right of the injection point in individuals with body mass index between 30-
40 kg/m2. It was determined that the difference between the individuals’ body mass indexes and 
the total tissue thicknesses 4 cm around the injection area was statistically significant. According to 
the statistical analysis (Tukey test) to determine which group this difference originated from, the 
difference between the tissue thicknesses above 4 cm of the injection point and the body mass 
index was determined from all groups. It was determined that the difference between the tissue 
thickness and body mass index 4 cm below the injection point, to the right and left of the injection 











Total Tissue Thicknesses (mm) 
2 cm above the 
injection point 
2 cm below the 
injection point 
2 cm right of the 
injection point 
2 cm left of the 
injection point 
 Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
18.5-24.9a 35.13 ±11.65* 40.76±12.45* 44.00±12.53* 38.19 ±12.84* 
25-29.9b 42.96 ± 9.78* 48.68±12.43 51.97±11.94 47.24±14.48 









Difference  a,b,c a a a 
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Table 5. Total Tissue Thickness Means Around 4 Cm of Injection Point and Body Mass 
Index Averages of Individuals. 




Total 150 people, 75 women and 75 men, were included in the study. It was determined 
that the subcutaneous tissue in women was thicker than the subcutaneous tissue in men. Similar 
results are seen in the literature (Burbridge, 2007; Kaya, Salmaslıoğlu, Terzi, Turan & Acunas, 2015; 
Larkin, Ashcroft, Elgellaie & Hickey, 2017; Nisbet, 2006). In the study conducted by Kaya et. al 
(2014), it was determined that the injections were made on the subcutaneous tissue on the 
dorsogluteal and ventrogluteal areas in 18 % of the women and this rate was 1.5% in men. 
However, it was determined that the muscle tissue and the total tissue thickness did not differ 
according to gender. Although the subcutaneous tissue thickness is higher in women in our study 
too, it was determined that there was no difference in men and women between the muscle tissue 
thickness and total tissue thicknesses.  
The subcutaneous tissue’s being thick is a situation which prevents to make injections into 
the muscles (Palma & Strokfus, 2013). The needle should pass the subcutaneous tissue and advance 
for at least 3 mm in the muscle tissue for the medicine to be given into the muscle tissue. In this 
situation, the length of the needle can differ according to the subcutaneous tissue thickness of the 
individuals in intramuscular injections. In our study, it was determined that the difference in 
subcutaneous tissue thickness according to body mass index was caused by individuals with a body 
mass index of 30-39.8 kg/m2. In these individuals, the thickening of the subcutaneous tissue may 
be a condition that prevents the drug to be given to the muscle tissue during intramuscular 
injections. In the study they conducted, Larkin et. al (2017) have reported that the subcutaneous 
tissue thickness should be less than 25 mm when 32 mm long needles are used in injections. In our 
study, the subcutaneous tissue thickness was found more than 25 mm or nearly 25 mm in 6 
individuals. It was determined that the body mass index of these individuals was between 24.5 and 
31.6 kg/m2 and 5 of them were female and 1 of them was male. Bayea and Nicoll (1995) observed 
the intramuscular injections made in 15 women in their studies. They reported that the medicine 
stayed in the subcutaneous tissue in the individuals whose subcutaneous tissue thickness was high 
on the dorsogluteal and ventrogluteal areas with 32 mm needles and 38 mm needles should be 
used.  They remarked that 51 mm (2 inches) long needles should be recommended in obese 
individuals whose subcutaneous tissue thickness was high but since these needles increased the 
pain, one should be careful while using them. In our study, the subcutaneous tissue thickness 
average was found 20.68±8.94 mm and the total tissue thickness average was found 53.01±14.02 
mm in the individuals with body mass index between 37.01 -39.8 kg/m2. The subcutaneous tissue 
thickness average was found 36.06 ±7.96 mm in 5 individuals with body mass index between 37.01 




Total Tissue Thicknesses (mm) 
4 cm above the 
injection point 
4 cm below the 
injection point 
4 cm right of the 
injection point 
4 cm left of the 
injection point 
 Mean ± SD Mean ± SD    Mean ± SD Mean ± SD 
18.5-24.9a 27.59±12.77* 39.40±10.82* 45.24±11.66* 36.35±13.69* 
25-29.9b 36.34±12.84* 46.26±13.69 53.60±12.18 44.35±14.02 
30-39.8c 43.90±14.78* 50.80±13.74 55.10±14.48 48.34±14.88 








Difference  a,b,c a a a 
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are used in these individuals. Similar results were obtained also in the studies conducted by Nispet, 
Kaya and Larkin et al.Damage of the bone tissue is a complication as serious as giving the medicine 
to the subcutaneous tissue in intramuscular injections (Wyaden, Landsborough, McGowan, 
Baigmohamad, Finn & Pennebaker, 2006). In ventrogluteal injections, the injection area’s being 
small may require turning to another injection area for the repeating injections. There should be at 
least 2 cm difference between the needle’s points of entering the tissue in each injection. In our 
study, the tissue thicknesses 2 and 4 cm around the ventrogluteal injection area were also analyzed.  
When the total tissue thicknesses 2 cm around the injection area were analyzed, it was seen 
that the total tissue thickness 2 cm above the injection area was 35.13±11.65 mm in body mass 
index between 18.5-24.9 kg/m2 individuals and it was 42.96±9.78 mm in individuals with normal 
weight. According to these results, the risk of bone damage increases when the injection was 
applied with 38 mm long needles 2 cm above the injection area in cachectic individuals. If it is 
thought that the needle should advance for 3 mm in the muscle tissue in the individuals with 
normal weight, it can be said that the total tissue thickness is liminal. 32 mm long needles can be 
used while making injection 2 cm above the injection area in these individuals.  
When the tissue thicknesses 4 cm around the injection area were analyzed, the total tissue 
thickness was found 27.59±12.77 mm 4 cm above the injection area in body mass index between 
18.5-24.9 kg/m2 individuals. It was found 39.40±10.82 4 cm below the injection area and 
36.35±13.69 mm 4 cm left of the area. The total tissue thickness was found 36.34±12.84 mm 4 cm 
above the injection area in the individuals who had normal weight. We can say that the possibility 
of bone damage is high or liminal in injections made with 38 mm long needles from these areas. 
Although the body mass index is important in terms of applying the injection into the 
subcutaneous tissue or the bone structures, the anthropometric structures of the individuals are also 
important in terms of injections (Larkin, Ashcroft, Elgellaie & Hickey, 2017). In our study, it was 
determined that the waist circumference, hip circumference, crista iliaca circumference and the 
subcutaneous tissue thickness were related. The subcutaneous tissue thickness increases in the 
individuals as their waist, hip, and crista iliaca circumference increases. Larkin et al compared the 
individuals’ waist and hip circumferences and body mass indexes and tissue thicknesses and formed 
an algorithm for ventrogluteal injection. In this algorithm, injection is not recommended for 
individuals under 65 kilograms, whose body mass index is below 25 and waist circumference is 75 
cm and below because of bone damage risk. When the same criteria were considered in our study, 
the total tissue thickness average in 17 individuals in these criteria was found 38±13,6 mm. 
According to this result, a result similar to the study conducted by Larkin et al was found in our 
study. A correlation on the positive direction was found between height and weight and the 
Trochanter-CIAS distance and Trochanter-crista iliaca distance. However, no correlation was 
determined between the subcutaneous tissue thickness and the muscle tissue thickness.  
 
Conclusions and Recommendations 
According to the results obtained from the study, the individuals’ weight and body mass 
index should be considered in the selection of the injection area and the length of the needles to be 
used while the ventrogluteal injection area is being used in intramuscular injections. Longer needles 
may be preferred especially in obese individuals. Besides, it should be thought that bone damage 
can occur 4 cm around the injection area in cachectic individuals and individuals with normal 
weight in repeating injections. Moreover, since the individuals’ waist and hip circumferences’ being 
high is also related to the subcutaneous tissue thickness, long needles also should be preferred in 
needle selection in these individuals.  
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Figure 1. Determination ventrogluteal area point.             Figure 2. Points around 2 and 4 cm     
ventrogluteal injection point. 
 
                                                         
Figure 3. Ultrason probe placed on injection points.             Fıgure 4. Subcutaneous and muscle 
tissue thicknesses. 
 
 
